A Study to Evaluate the Use of an Indwelling Catheter to Obtain Cerebrospinal Fluid (CSF) by Low-rate Continuous Sampling (MK-0000-211)
NCT01325662 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 11
Last updated 2015-07-23
Summary
This is a study to evaluate the feasibility and tolerability of low-rate continuous Cerebrospinal Fluid (CSF) sampling and to estimate the number of participants who exhibit severe baseline instability of CSF amyloid beta isoform Aß40 concentrations in healthy participants.
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Max Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-03-31
- Primary Completion
- 2011-09-30
- Completion
- 2011-09-30
More Related Trials
-
MR Evaluation of Cerebrospinal Fluid (CSF) Dynamics
NCT04099823 ·Status: RECRUITING ·Phase: NA
-
Cerebrospinal Fluid (CSF) Biomarkers Alzheimer's Disease (AD) and Non-AD Dementias
NCT01730430 ·Status: COMPLETED
-
Human Amniotic Mesenchymal Cell Secretome for Neurodegeneration and Neuroinflammation
NCT06551649 ·Status: RECRUITING ·Phase: NA
-
New CSF Biomarkers for Alzheimer's Disease
NCT03621839 ·Status: RECRUITING
-
Development of an EEG Diagnostic for Alzheimer's Disease
NCT04954183 ·Status: COMPLETED
-
18F-Florbetaben PET Amyloid Imaging in Case of Intermediate CSF Biology for the Diagnosis of Alzheimer's Disease : a Pilot Study
NCT02556502 ·Status: COMPLETED ·Phase: NA
-
Assessment of Cerebrospinal Fluid Flow Related Disorders Using a Phase-contrast Magnetic Resonance Imaging Technique.
NCT03656016 ·Status: RECRUITING
-
A Study to Assess Regional Cerebral Blood Flow as an Alzheimer's Disease Biomarker Compared to Positron Emission Tomography in Patients With Mild-to-Moderate Alzheimer's Disease and Cognitively Normal Elderly Subjects (Study MK-0000-068)(COMPLETED)
NCT00757939 ·Status: COMPLETED ·Phase: PHASE1
-
Magnetic Resonance Imaging for the Study of Patients With Neurological Disorders
NCT00001362 ·Status: COMPLETED
-
Study of Tau Imaging With the Use of [18F]MK-6240 Tracer
NCT04104659 ·Status: ENROLLING_BY_INVITATION
-
Draw-10: A Weekly Blood Draw Study to Understand the Biological Variability of Plasma pTau-217
NCT06742944 ·Status: COMPLETED
-
Positron Emission Tomography of Amyloid in Alzheimer's Disease
NCT00205621 ·Status: SUSPENDED ·Phase: PHASE1
-
A Biospecimen and Clinical Data Study on Patients for Drug & Biomarker Discovery
NCT01592552 ·Status: COMPLETED
-
Measuring Fluid Flow in the Brain Using Alcohol and MRI in Healthy Participants
NCT04608292 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Detecting Traumatic Intracranial Hemorrhage With Microwaves and Biomarkers
NCT04666766 ·Status: RECRUITING ·Phase: NA
-
PET Measures of CSF Clearance in Preclinical Alzheimer's Disease
NCT03663387 ·Status: COMPLETED
-
Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
NCT03225144 ·Status: RECRUITING
-
New Biomarker for Alzheimer's Disease Diagnostic
NCT01315639 ·Status: COMPLETED ·Phase: NA
-
Amantadine and Functional Improvement Following ABI Measured by MRI Tractography; A Pilot Study
NCT02566720 ·Status: UNKNOWN ·Phase: NA
-
Measuring Cerebral Blood Flow Using Pseudo-continuous Arterial Spin Labeling Perfusion Magnetic Resonance Imaging
NCT02767609 ·Status: COMPLETED ·Phase: NA
-
Molecular Cerebral Imaging in Incipient Dementia (MCI-ID) II
NCT02317250 ·Status: WITHDRAWN ·Phase: PHASE3
-
African American Alzheimer's Progression Markers - CSF and Neuro-Imaging
NCT02089555 ·Status: COMPLETED
-
Amyloid Beta-peptide 1-40 and Alzheimer's Disease
NCT02770482 ·Status: COMPLETED ·Phase: NA
-
Longitudinal Assessment of Protein Markers in the Cerebrospinal Fluid of Patients With Central Nervous System Involvement
NCT07313098 ·Status: NOT_YET_RECRUITING
-
HEAD Injury Serum Markers and Multi-modalities for Assessing Response to Trauma
NCT04423198 ·Status: UNKNOWN